200 related articles for article (PubMed ID: 15202788)
1. Plasma levels of 7-hydroxylated dehydroepiandrosterone (DHEA) metabolites and selected amino-thiols as discriminatory tools of Alzheimer's disease and vascular dementia.
Bicíková M; Rípová D; Hill M; Jirák R; Havlíková H; Tallová J; Hampl R
Clin Chem Lab Med; 2004 May; 42(5):518-24. PubMed ID: 15202788
[TBL] [Abstract][Full Text] [Related]
2. Neurosteroids: Cerebrospinal fluid levels for Alzheimer's disease and vascular dementia diagnostics.
Kim SB; Hill M; Kwak YT; Hampl R; Jo DH; Morfin R
J Clin Endocrinol Metab; 2003 Nov; 88(11):5199-206. PubMed ID: 14602750
[TBL] [Abstract][Full Text] [Related]
3. Decreased dehydroepiandrosterone (DHEA) and dehydroepiandrosterone sulfate (DHEAS) concentrations in plasma of Alzheimer's disease (AD) patients.
Aldred S; Mecocci P
Arch Gerontol Geriatr; 2010; 51(1):e16-8. PubMed ID: 19665809
[TBL] [Abstract][Full Text] [Related]
4. Plasma total homocysteine and cysteine levels as cardiovascular risk factors in coronary heart disease.
Ozkan Y; Ozkan E; Simşek B
Int J Cardiol; 2002 Mar; 82(3):269-77. PubMed ID: 11911915
[TBL] [Abstract][Full Text] [Related]
5. Dehydroepiandrosterone sulphate (DHEAS) in the oldest old, aged 85 and over.
Birkenhäger-Gillesse EG; Derksen J; Lagaay AM
Ann N Y Acad Sci; 1994 May; 719():543-52. PubMed ID: 8010622
[TBL] [Abstract][Full Text] [Related]
6. [Plasma levels of endogenous hydrogen sulfide and homocysteine in patients with Alzheimer's disease and vascular dementia and the significance thereof].
Liu XQ; Liu XQ; Jiang P; Huang H; Yan Y
Zhonghua Yi Xue Za Zhi; 2008 Aug; 88(32):2246-9. PubMed ID: 19087670
[TBL] [Abstract][Full Text] [Related]
7. Bound homocysteine, cysteine, and cysteinylglycine distribution between albumin and globulins.
Hortin GL; Seam N; Hoehn GT
Clin Chem; 2006 Dec; 52(12):2258-64. PubMed ID: 17068168
[TBL] [Abstract][Full Text] [Related]
8. Serum levels of pregnenolone and 17-hydroxypregnenolone in patients with rheumatoid arthritis and systemic lupus erythematosus: relation to other adrenal hormones.
Vogl D; Falk W; Dorner M; Schölmerich J; Straub RH
J Rheumatol; 2003 Feb; 30(2):269-75. PubMed ID: 12563679
[TBL] [Abstract][Full Text] [Related]
9. Sex differences due to dehydroepiandrosterone (DHEA) feeding affecting dehydroepiandrosterone sulfate secretion in golden Syrian hamsters.
Maeda Y; Nagatomo J; Sueta H; Tanaka S; Ota Y; Shiotsuki H; Eto T; Kai M; Kondo K; Chijiiwa K
Horm Metab Res; 2004 Feb; 36(2):107-10. PubMed ID: 15002061
[TBL] [Abstract][Full Text] [Related]
10. Allopregnanolone and dehydroepiandrosterone response to corticotropin-releasing factor in patients suffering from Alzheimer's disease and vascular dementia.
Bernardi F; Lanzone A; Cento RM; Spada RS; Pezzani I; Genazzani AD; Luisi S; Luisi M; Petraglia F; Genazzani AR
Eur J Endocrinol; 2000 May; 142(5):466-71. PubMed ID: 10802523
[TBL] [Abstract][Full Text] [Related]
11. Serum dehydroepiandrosterone sulfate in Alzheimer's disease and in multi-infarct dementia.
Näsman B; Olsson T; Bäckström T; Eriksson S; Grankvist K; Viitanen M; Bucht G
Biol Psychiatry; 1991 Oct; 30(7):684-90. PubMed ID: 1835658
[TBL] [Abstract][Full Text] [Related]
12. Determination of 17alpha-hydroxypregnenolone sulfate and its application in diagnostics.
Vceláková H; Hill M; Lapcík O; Parízek A
Steroids; 2007 Apr; 72(4):323-7. PubMed ID: 17298837
[TBL] [Abstract][Full Text] [Related]
13. Serum dehydroepiandrosterone (DHEA) and DHEA-sulfate (DHEA-S) in Alzheimer's disease and in cerebrovascular dementia.
Yanase T; Fukahori M; Taniguchi S; Nishi Y; Sakai Y; Takayanagi R; Haji M; Nawata H
Endocr J; 1996 Feb; 43(1):119-23. PubMed ID: 8732462
[TBL] [Abstract][Full Text] [Related]
14. Serum dehydroepiandrosterone, dehydroepiandrosterone sulfate, and pregnenolone sulfate concentrations in patients with hyperthyroidism and hypothyroidism.
Tagawa N; Tamanaka J; Fujinami A; Kobayashi Y; Takano T; Fukata S; Kuma K; Tada H; Amino N
Clin Chem; 2000 Apr; 46(4):523-8. PubMed ID: 10759476
[TBL] [Abstract][Full Text] [Related]
15. Rapid column-switching liquid chromatography/mass spectrometric assay for DHEA-sulfate in the plasma of patients with Alzheimer's disease.
Cho SH; Jung BH; Lee WY; Chung BC
Biomed Chromatogr; 2006 Oct; 20(10):1093-7. PubMed ID: 16583455
[TBL] [Abstract][Full Text] [Related]
16. Plasma levels of homocysteine and cysteine increased in pediatric NAFLD and strongly correlated with severity of liver damage.
Pastore A; Alisi A; di Giovamberardino G; Crudele A; Ceccarelli S; Panera N; Dionisi-Vici C; Nobili V
Int J Mol Sci; 2014 Nov; 15(11):21202-14. PubMed ID: 25407526
[TBL] [Abstract][Full Text] [Related]
17. Cortisol, dehydroepiandrosterone (DHEA), and DHEA sulfate in the cerebrospinal fluid of man: relation to blood levels and the effects of age.
Guazzo EP; Kirkpatrick PJ; Goodyer IM; Shiers HM; Herbert J
J Clin Endocrinol Metab; 1996 Nov; 81(11):3951-60. PubMed ID: 8923843
[TBL] [Abstract][Full Text] [Related]
18. Relationships between dehydroepiandrosterone sulfate (DHEAS) and cortisol (CRT) plasma levels and everyday memory in Alzheimer's disease patients compared to healthy controls.
Carlson LE; Sherwin BB; Chertkow HM
Horm Behav; 1999 Jun; 35(3):254-63. PubMed ID: 10373337
[TBL] [Abstract][Full Text] [Related]
19. Six-month oral dehydroepiandrosterone supplementation in early and late postmenopause.
Stomati M; Monteleone P; Casarosa E; Quirici B; Puccetti S; Bernardi F; Genazzani AD; Rovati L; Luisi M; Genazzani AR
Gynecol Endocrinol; 2000 Oct; 14(5):342-63. PubMed ID: 11109974
[TBL] [Abstract][Full Text] [Related]
20. Increased total 7 alpha-hydroxy-dehydroepiandrosterone in serum of patients with Alzheimer's disease.
Attal-Khémis S; Dalmeyda V; Michot JL; Roudier M; Morfin R
J Gerontol A Biol Sci Med Sci; 1998 Mar; 53(2):B125-32. PubMed ID: 9520908
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
